Tag: Atrial Fibrillation

Viz.ai, Bristol Myers Squibb sign deal for AI algorithm and Viz HCM software

businessnewstoday- March 4, 2023

Viz.ai, an artificial intelligence (AI) powered health technology company, has signed a multi-year agreement with Bristol Myers Squibb (BMY) to provide the latter with an ... Read More

Zydus Lifesciences bags FDA final approval for Apixaban Tablets

businessnewstoday- March 1, 2023

Zydus Lifesciences has bagged final approval from the US Food and Drug Administration (FDA) for Apixaban Tablets, 2.5mg and 5mg, a generic version of Eliquis ... Read More

US medical device company Adagio Medical raises $42.5m in Series E

pharmanewsdaily- November 15, 2020

Adagio Medical, a California-based medical device company focused on developing treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), has raised $42.5 million in a ... Read More

CATALYST clinical trial : FDA approves Abbott’s trial of Amplatzer Amulet device in AF

pharmanewsdaily- February 4, 2020

Abbott has been granted approval from the US Food and Drug Administration (FDA) for the CATALYST clinical trial to assess its Amplatzer Amulet Left Atrial ... Read More

Micro Labs, Mylan secure FDA approval for first generics of Eliquis

pharmanewsdaily- December 26, 2019

Micro Labs and Mylan Pharmaceuticals have secured approval from the US Food and Drug Administration (FDA) for two applications for the first generics of Eliquis ... Read More

FDA rejects Correvio Pharma’s anti-arrhythmic drug Brinavess

pharmanewsdaily- December 25, 2019

Correvio Pharma said that the US Food and Drug Administration (FDA) decided not to approve its anti-arrhythmic drug Brinavess (vernakalant IV). In this connection, the ... Read More